Hapten Sciences, Inc.
PrivateLast Round
VC Round
Aug 19, 2021
Total Funding Raised
$808,820
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hapten Sciences, Inc. operates in Healthcare & Life Sciences and is based in Memphis, Tennessee. Its latest recorded funding round was a VC Round in August 2021.
Hapten Sciences, Inc. is a biopharmaceutical company that develops novel, early-stage molecular drugs, including a vaccine-like therapy for the prevention of contact dermatitis caused by urushiol oil.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hapten Sciences, Inc. Comparables
Compare Hapten Sciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BOME Therapeutics | 93% | |
| Edesa Biotech Inc | 61% | |
| Almirall | 61% |
For institutional investors. Book with your work email.
Hapten Sciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 19, 2021 | ||||
| VC Round | Sep 25, 2018 | ||||
| VC Round | Jan 2, 2014 | ||||
| Grant | Sep 20, 2011 | ||||
| VC Round | Jun 2, 2011 |
For institutional investors. Book with your work email.
Hapten Sciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| MB Venture Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased by 43% MoM.
- Apr 20, 2026
Monthly visitors increased 47% MoM.
For institutional investors. Book with your work email.
Hapten Sciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hapten Sciences, Inc.'s valuation, stock price, and market status.
Is Hapten Sciences, Inc. a public or private company?
Hapten Sciences, Inc. is a private company.
What is the current stock price of Hapten Sciences, Inc.?
Hapten Sciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Hapten Sciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hapten Sciences, Inc. worth (valuation)?
Valuation information for Hapten Sciences, Inc. is not publicly available.
Can I buy Hapten Sciences, Inc. stock?
Hapten Sciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hapten Sciences, Inc.'s last funding round?
Hapten Sciences, Inc.'s most recent funding round was VC Round on August 19, 2021.
Who are the main investors in Hapten Sciences, Inc.?
Key investors in Hapten Sciences, Inc. include National Institute of Allergy and Infectious Diseases, MB Venture Partners.
Will Hapten Sciences, Inc. IPO soon?
No public IPO plans have been announced for Hapten Sciences, Inc..
How can I track Hapten Sciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Hapten Sciences, Inc.'s shares on secondary markets.